Antinociception by tricyclic antidepressants in the rat formalin test: Differential effects on different behaviours following systemic and spinal administration

Pain

Volumn 93, Issue 1, 2001, Pages 51-59

  Sawynok, Jana ^a   Reid, Allison ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Amitriptyline; Antidepressants; Formalin test; Inflammation; Intrathecal

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DESIPRAMINE; FORMALDEHYDE; IMIPRAMINE; NORTRIPTYLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BEHAVIOR; BITE; CANNULATION; CONTROLLED STUDY; DISSOCIATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; INTERSTITIAL FLUID; LICKING; LUMBAR PUNCTURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL ANESTHESIA;

AMITRIPTYLINE; ANALGESICS; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FOOT; FORMALDEHYDE; HYPNOTICS AND SEDATIVES; INJECTIONS, SPINAL; MALE; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0034983796     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(01)00291-3     Document Type: Article

References (74)

1. The formalin test: Scoring properties of the first and second phases of the pain response in rats
2. Improving the efficiency of the formalin test
3. The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain
4. Amitriptyline produces analgesia in the formalin pain test
5. Unilateral knife cuts produce ipsilateral suppression of responsiveness to pain in the formalin test
6. Noradrenergic and opioidergic influences on the antinociceptive effect of clomipramine in the formalin test in rats
7. Antinociceptive effects of acute and 'chronic' injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats
8. Mechanism of inhibition of experimental inflammation by antidepressant drugs
9. Clomipramine differently affects inflammatory edema and pain in the rat
10. Fluoxetine reduces inflammatory edema in the rat: Involvement of the pituitary-adrenal axis
11. Effects of clomipramine and fluoxetine on subcutaneous carrageenin-induced inflammation in the rat
12. Behavioral tolerance to and withdrawal from multiple fluoxetine administration
13. Spinal cord adenosine receptor stimulation in rats inhibits peripheral neutrophil accumulation. The role of N-methyl-D-aspartate receptors
14. Studies on the acute inflammatory response. I. Involvement of the central nervous system in certain models of inflammation
15. Reduction of arthritis and pain behaviour following chronic administration of amitriptyline or imipramine in rats with adjuvant-induced arthritis
16. Test-dependent relationship of the antidepressant and analgesic effects of amitriptyline
17. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat
18. Peripheral and central hyperexcitability: Differential signs and symptoms in persistent pain
19. The formalin test: A validation of the weighted-scores method of behavioural pain rating
20. Specific contribution of lumbar spinal mechanisms to persistent nociceptive responses in the formalin test
21. Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics
22. Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors
23. Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones
24. Site- and test-dependent antinociceptive efficacy of amitriptyline in rats
25. The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats
26. Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats
27. Tricyclic and other antidepressants as analgesics
28. Acute amitriptyline in a rat model of neuropathic pain: Differential symptom and route effects
29. Changes in nociception after acute and chronic administration of zimelidine: Different effects in the formalin test and the substance P behavioural assay
30. A receptors
31. Afferent C-fibre and A-delta activity in models of inflammation
32. Formalin test in mice, a useful technique for evaluating mild analgesics
33. Analgesic properties of intrathecally administered heterocyclic antidepressants
34. Imipramine inhibits intrathecal substance P-induced behavior and blocks spinal cord substance P receptors in mice
35. The effects of mexilitine, desipramine and fluoxetine in rat models involving central sensitization
36. A new automated method of pain scoring in the formalin test in rats
37. Analgesic effect of antidepressant drugs
38. Differential responsiveness of inbred strains of rats to antidepressants in the forced swimming test: Are Wistar Kyoto rats an animal model of subsensitivity to antidepressants?
39. Effect of antidepressants on specific neurotransmitters: Are such effects relevant to the therapeutic action?
40. Chronic administration of desipramine and zimelidine changes the behavioural response in the formalin test in rats
41. Formalin pain is expressed in decerebrate rats but not attenuated by morphine
42. Effects of partial decortication on opioid analgesia in the formalin test
43. Antidepressants as analgesics
44. A systematic review of antidepressants in neuropathic pain
45. Reduction of NMDA-induced behaviour after acute and chronic administration of desipramine in mice
46. Antidepressant-induced analgesia in chronic non-malignant pain: A meta-analysis of 39 placebo-controlled studies
47. The effects of different monoaminergic antidepressants on the analgesia induced by spinal cord adrenal medullary transplants in the formalin test in rats
48. Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat
49. Spatial and temporal aspects of spinal cord and brainstem activation in the formalin pain model
50. Formalin-evoked activity in identified primary afferent fibres: Systemic lidocaine suppresses phase-2 activity
51. The effect of diazepam on nociception in mice
52. The formalin test in mice: Effect of formalin concentration
53. B mechanism involvement
54. Modulation of nociception by descending serotonergic projections
55. Peripheral antinociceptive action of amitriptyline in the rat formalin test: Involvement of adenosine
56. Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat
57. Autotomy behavior in rats following peripheral deafferentation is suppressed by daily injections of amitriptyline, diazepam and saline
58. Antidepressants as analgesics
59. Centrally administered non-NMDA but not NMDA receptor antagonists block peripheral knee joint inflammation
60. Joint inflammation and hyperalgesia are reduced by spinal bicuculline
61. Analgesic activity of tricyclic antidepressants
62. Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action
63. Lesions of bulbo-spinal serotonergic or noradrenergic pathways reduce nociception as measured by the formalin test
64. The formalin test: An evaluation of the method
65. Participation of opioid and monoaminergic mechanisms on the antinociceptive effect induced by tricyclic antidepressants in two behavioural pain tests in mice
66. The differential effects of lateral midbrain lesions on the two phases of formalin pain
67. Antinociceptive properties of fenfluramine, a serotonin reuptake inhibitor, in a rat model of neuropathy
68. Standardization of the rat paw formalin test for the evaluation of analgesics
69. Neurogenic and tissue-mediated components of formalin-induced edema: Evidence for supraspinal regulation
70. Naloxone causes apparent antinociception and pronociception simultaneously in the rat paw formalin test
71. The rat paw formalin test: Comparison of noxious agents
72. The pathophysiology of chronic pain - Increased sensitivity to low threshold Aβ-fibre inputs
73. Chronic catheterization of the spinal subarachnoid space
74. 2, and hyaluronic acid production in human synovial cells and synovial tissue cultures